[ad_1]
A Reuters report on Friday found that the World Health Organization clinical trial of 11,026 patients in more than 30 countries found the effects of remedicivir produced by Gilead Sciences Inc. in the United States.
The study, which worked with four drugs, evaluated the efficacy of hydroxychloroquine, anti-AIDS lopinavir / ritonavir and interferon in addition to remediciv.
The World Health Organization (WHO) said on Thursday that research had shown the drugs had little or no effect in reducing hospital stay or death in patients admitted to hospital with Kovid-19.
The results of this study have not yet been reviewed. However, it has been uploaded to the previous server.
China’s National Health Commission (NHC) approved the application of Lopinavir and Ritonavir in Covid-19 positive patients in February, despite no evidence from clinical trials in the desperate situation, given the increase in the number of infections and deaths.
The United States said in April that it had “clear” evidence of its supporting role. Later in May, the US Food and Drug Administration (FDA) received emergency approval for Remedicevir; Since then, several countries have been using this drug to prevent Ebola in the treatment of patients with Kovid-19.
He was also receiving treatment from the President of the United States, Donald Trump, after he was recently diagnosed with the coronavirus.
SKF, Beximco presented a sample of Remdesivir
Covid-19: RemedicV production started in Bangladesh
The United States has found “clear” evidence of Remedicivir’s ability to cure coronavirus
India allowed the use of corrective treatments for the treatment of Covid-19
It will reach RAMDCV in two or three days: Minister of Health
A Gilead study of the efficacy of remedicivir in the United States earlier this month claimed that those who took the drug recovered at least five days earlier than those who took placebo.
Gilead said it found evidence in a study of 1,072 people.
The US company has now called the World Health Organization study “inappropriate.” They have pointed out that the research data has not yet been reviewed.
China uses HIV drugs to treat coronavirus
Japanese Flu Drug Effective in Coronavirus Treatment: China
Soumya Swaminathan, chief scientist at the World Health Organization, said Wednesday that the application of hydroxychloroquine and lopinavir / ritonavir was stopped in June because the study had proven ineffective. However, research on other drugs was continued in 500 hospitals in 30 countries.
“We are thinking about the next one,” he said. We are looking for monoclonal antibodies; We are thinking about immunomodulators and some new antiviral drugs that have been developed in recent months ”.
[ad_2]
